Literature DB >> 25449230

Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children.

Meijuan Wang1, Yuqing Wang1, Yongdong Yan1, Canhong Zhu1, Li Huang1, Xuejun Shao2, Jun Xu2, Hong Zhu2, Xiangle Sun3, Wei Ji4, Zhengrong Chen5.   

Abstract

OBJECTIVES: The purpose of this study was to explore the clinical and laboratory characteristics of children with refractory Mycoplasma pneumoniae pneumonia (RMPP).
METHODS: Seventy-six children with RMPP and 26 children with non-refractory M. pneumoniae pneumonia (NRMPP), confirmed by both serology and fluorescent quantitation PCR in bronchoalveolar lavage fluid (BALF), were evaluated retrospectively.
RESULTS: Compared to those with NRMPP, children with RMPP were older (66.6±39.0 vs. 48.4±35.4 months, p=0.038) and had a longer duration of fever (12.7±2.6 vs. 7.5±1.8 days) and hospital stay (12.1±3.2 vs. 7.4±2.9 days). Children with RMPP presented neutrophil infiltration both in serum and BALF, as well as severe pulmonary lesions with pleural effusion. Children with RMPP had a significantly higher M. pneumoniae DNA load in BALF compared to NRMPP patients, and the M. pneumoniae load in BALF was significantly correlated with neutrophils and inversely correlated with macrophages for both the NRMPP and RMPP groups. The serum concentrations of tumor necrosis factor alpha (median 114.5 pg/ml, range 49.1-897.9 pg/ml) and interferon gamma (median 376.9 pg/ml, range 221.4-1997.6 pg/ml) were significantly higher in children with RMPP compared to children with NRMPP.
CONCLUSIONS: This study indicates that a direct microbe effect and the subsequent induced excessive host immune response contribute in part to the progression of RMPP.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Children; Clinical characteristics; Refractory Mycoplasma pneumoniae pneumonia

Mesh:

Substances:

Year:  2014        PMID: 25449230     DOI: 10.1016/j.ijid.2014.07.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  36 in total

1.  Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study.

Authors:  Lizhen Huang; Xia Huang; Wujiang Jiang; Rong Zhang; Yongdong Yan; Li Huang
Journal:  BMJ Open       Date:  2018-12-18       Impact factor: 2.692

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

Review 4.  Mycoplasma pneumoniae Infections and Primary Immune Deficiencies.

Authors:  Dimitri Poddighe; Erkan Demirkaya; Vitaliy Sazonov; Micol Romano
Journal:  Int J Clin Pract       Date:  2022-07-08       Impact factor: 3.149

5.  A prediction study of IL-18 and IFN-γ in glucocorticoid treatment response in infants and young children with severe Mycoplasma pneumoniae pneumonia.

Authors:  Ruochen Zhu; Song Mao; Wenjing Shi; Liangxia Wu; Jianhua Zhang
Journal:  Transl Pediatr       Date:  2022-05

Review 6.  Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management.

Authors:  Lin Tong; Shumin Huang; Chen Zheng; Yuanyuan Zhang; Zhimin Chen
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

7.  Hepatocyte growth factor can guide treatment of Mycoplasma pneumoniae pneumonia in children.

Authors:  Lun Qin Liu; Zhi Hua Wang; Hai Yun Yao
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

8.  Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia.

Authors:  Zhengrong Chen; Xuejun Shao; Xunwu Dou; Xinxing Zhang; Yuqing Wang; Canhong Zhu; Chuangli Hao; Mingyue Fan; Wei Ji; Yongdong Yan
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children.

Authors:  Yuanyuan Zhang; Shufen Mei; Yunlian Zhou; Meixia Huang; Guijuan Dong; Zhimin Chen
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

10.  The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yuanyuan Zhang; Yunlian Zhou; Shuxian Li; Dehua Yang; Xiling Wu; Zhimin Chen
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.